A trimethyl lock successfully stabilizes a nascent Michael acceptor for prodrug applications.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: A trimethyl lock successfully stabilizes a nascent Michael acceptor for prodrug applications.
Συγγραφείς: Cheema EK; Department of Chemistry, Johns Hopkins University, Baltimore, MD 21218, USA. rokita@jhu.edu., Rokita SE; Department of Chemistry, Johns Hopkins University, Baltimore, MD 21218, USA. rokita@jhu.edu.
Πηγή: Chemical communications (Cambridge, England) [Chem Commun (Camb)] 2026 Oct 15; Vol. 62 (81), pp. 20326-20329. Date of Electronic Publication: 2026 Oct 15.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 9610838 Publication Model: Electronic Cited Medium: Internet ISSN: 1364-548X (Electronic) Linking ISSN: 13597345 NLM ISO Abbreviation: Chem Commun (Camb) Subsets: MEDLINE
Imprint Name(s): Original Publication: Cambridge : Royal Society of Chemistry
Ιατρικοί όροι (MeSH): Prodrugs*/chemistry , Prodrugs*/pharmacology , Prodrugs*/metabolism , STAT3 Transcription Factor*/antagonists & inhibitors , STAT3 Transcription Factor*/metabolism , Pyrones*/chemistry , Pyrones*/pharmacology, NAD(P)H Dehydrogenase (Quinone)/metabolism ; Humans
Περίληψη: 5-Hydroxy-γ-pyrone-based Michael acceptors have repeatedly registered as hits in screens for inhibiting key therapeutic targets, but their aqueous instability has prevented further development. Here, we report a method to stabilize such an inhibitor of STAT3 with a trimethyl lock until reduction by hNQO1, an enzyme typically overexpressed in hypoxic tumors.
Substance Nomenclature: 0 (Prodrugs)
0 (STAT3 Transcription Factor)
EC 1.6.5.2 (NAD(P)H Dehydrogenase (Quinone))
0 (Pyrones)
Entry Date(s): Date Created: 20260921 Date Completed: 20261015 Latest Revision: 20261015
Update Code: 20261016
DOI: 10.1039/d6cc05508g
PMID: 42766013
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:1364-548X
DOI:10.1039/d6cc05508g